Average Co-Inventor Count = 3.47
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rhone-poulenc Rorer Pharmaceuticals Inc. (14 from 111 patents)
2. Rorer Pharmaceutical Corporation (8 from 109 patents)
3. Aventis Pharmaceuticals Inc. (2 from 207 patents)
4. William H. Rorer, Inc. (2 from 146 patents)
5. Sanofi-aventis (1 from 389 patents)
27 patents:
1. 8143242 - Malonamide derivatives with antithrombotic activity
2. 7612075 - Substituted oxoazaheterocyclyl compounds
3. 6977263 - Chemical compounds
4. 6057369 - Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl)
5. 5596020 - Amino bi- and tri-carbocyclic alkane bis-aryl squalene synthase
6. 5561143 - Aliphatic amino bis-aryl squalene synthase inhibitors
7. 5534532 - Aliphatic amino bis-aryl squalene synthase inhibitors
8. 5494918 - Multicyclic tertiary amine polyaromatic squalene syntase inhibitors
9. 5455260 - Aliphatic amino bis-aryl squalene synthase inhibitors
10. 5451596 - Cycloalkyl amine bis-aryl squalene synthase inhibitors
11. 5395846 - Amino Bi- and tri-carbocyclic aklane bis-aryl squalene synthase
12. 5385912 - Multicyclic tertiary amine polyaromatic squalene synthase inhibitors
13. 5001128 - HMG-COA reductase inhibitors
14. 5001144 - Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
15. 4996234 - HMG-CoA reductase inhibitors